Correct developmental expression level of Rai1 in forebrain neurons is required for control of body weight, activity levels and learning and memory

Hum Mol Genet. 2014 Apr 1;23(7):1771-82. doi: 10.1093/hmg/ddt568. Epub 2013 Nov 11.

Abstract

Potocki-Lupski syndrome (PTLS) is a genomic disorder associated with an ∼3 Mb duplication in 17p11.2. Clinical features include leanness, intellectual disability, autistic features and developmental deficits. RAI1 gene dosage is associated with the PTLS phenotypes. To understand where and when Rai1 overexpression is detrimental, we generated a mouse that over-expresses Rai1 conditionally in forebrain neurons (I-Rai1). Phenotypic characterization of I-Rai1 mice showed significant underweight, hyperactivity and impaired learning and memory ability compared with wild-type littermates. Doxycycline administration can turn off the transgene expression allowing the restoration of Rai1 normal expression levels. When the transgene was turned off from conception to 3 months of age, no phenotypic differences were observed between I-Rai1 and their wild-type littermates. Surprisingly, we found that turning off the transgene expression before the onset of the phenotypes (1-3 months) or after the onset of the phenotypes (3-5 months) cannot prevent nor reverse the phenotypic outcomes. Our results indicate that Rai1 dosage in forebrain neurons is critical during the development and is related to body weight regulation, activity levels and learning and memory.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Body Weight / genetics
  • Chromosome Disorders
  • Chromosome Duplication
  • Disease Models, Animal
  • Doxycycline / pharmacology
  • Gene Dosage / genetics*
  • Hyperkinesis / genetics*
  • Intellectual Disability / genetics
  • Maze Learning / physiology*
  • Memory / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred CBA
  • Mice, Transgenic
  • Motor Activity / genetics
  • Prosencephalon / metabolism*
  • Smith-Magenis Syndrome / genetics
  • Trans-Activators / biosynthesis
  • Trans-Activators / genetics*
  • Transgenes / drug effects
  • Transgenes / genetics

Substances

  • Anti-Bacterial Agents
  • Rai1 protein, mouse
  • Trans-Activators
  • Doxycycline

Supplementary concepts

  • Potocki-Lupski syndrome